September 18, 2012

Generic drug makers Hospira, Sagent Pharmaceuticals and Teva Pharmaceutical Industries have launched generic versions of a chemotherapy drug made by Sanofi, the three companies said last month.


September 11, 2012

Sagent Pharmaceuticals has launched a drug used to treat complications related to chemotherapy, the drug maker said.

August 30, 2012

The Food and Drug Administration has approved a biosimilar drug made by Teva Pharmaceutical Industries for a condition that results from certain chemotherapy treatments, the drug maker said Thursday.

August 15, 2012

A division of Teva Pharmaceutical Industries has launched a generic chemotherapy drug, the company said.

August 9, 2012

Hospira has relaunched a generic chemotherapy drug for the U.S. market, the generic drug maker said Thursday.

August 9, 2012

Drug maker Sagent Pharmaceuticals has launched a generic chemotherapy drug, the company said Thursday.

August 6, 2012

The Food and Drug Administration has approved a new drug for treating colorectal cancer that has spread to other parts of the body, the agency said Friday.

May 17, 2012

Sagent Pharmaceuticals has launched a generic version of a chemotherapy drug, the company said Thursday.

April 27, 2012

The Food and Drug Administration has approved a drug made by GlaxoSmithKline for certain cancer patients.

April 3, 2012

Mylan has released a generic version of a drug used to treat a complication of certain chemotherapy regimens, the drug maker said Tuesday.

April 3, 2012

Psi Bands, stylish drug-free wristbands for the relief of nausea, were voted the most buzz-worthy product of the year at the Travel Goods Association trade show held in Las Vegas, the company announced earlier this month. The "Buzz Award" is given once per year to the product that has created the most "buzz" at the Travel Goods Show's New Products Pavilion as voted on by retailers and members of the press.

March 30, 2012

Breast cancer patients taking an experimental drug made by Roche subsidiary Genentech lived significantly longer than those taking another drug made by GlaxoSmithKline, according to results of a late-stage clinical trial.

March 23, 2012

Lawmakers are going after companies that they say have sought to take advantage of drug shortages by buying drugs in short supply and then reselling them at higher prices, according to published reports.

March 21, 2012

A Food and Drug Administration expert panel delivered a favorable vote on a cancer drug made by GlaxoSmithKline.

March 16, 2012

Pills for treating cancer have created numerous alternatives to spending hours in a clinic or at home receiving chemotherapy infusions, but risks of drug interactions remain, according to a new survey by the research arm of pharmacy benefit manager Medco Health Solutions.

March 7, 2012

The Food and Drug Administration has declined to approve a drug made by Eisai for leukemia in certain elderly patients, the drug maker said.

February 24, 2012

Walgreens Specialty Pharmacy on Thursday released data showing that both patients and their health plans can realize savings of up to 60% on the cost of infused specialty medications by choosing alternate treatment sites.

February 23, 2012

A Northern Ireland pharmaceutical company has acquired a chemotherapy agent from Gilead.

February 22, 2012

Psi Bands on Wednesday announced its line of fashionable nausea-relief bands was recently recognized with Kimberly Clark's Huggies MomInspired Grant, a grant program designed to recognize and support inspirational and entrepreneurial moms.

January 19, 2012

Drug maker Sandoz has started two late-stage clinical trials of biosimilar drugs for treating cancer patients undergoing chemotherapy, the company said Thursday, saying the studies were meant to support the drugs' eventual marketing in the United States.

November 18, 2011

The Food and Drug Administration has approved a new chemotherapy drug for treating acute lymphoblastic leukemia, the agency said Friday.

November 8, 2011

The University of Arizona Cancer Center, in partnership with Walgreens, last month opened a specialty outpatient pharmacy on-site to meet the needs of its patients.

November 7, 2011

The Food and Drug Administration has approved a drug made by Bristol-Myers Squibb for treating head and neck cancer, the agency said Monday.

September 28, 2011

Sagent Pharmaceuticals has launched its new chemotherapy drug.